Dario Giugliano (D Giugliano)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 31

Top Topics

Ankylosing Spondylitis

Systematic Review

Glycemic Control

Top Venues

Diabetes, obesity & metabolism

Cardiovascular diabetology

This page only lists publications with an associated author ORCID identifier.

Publications

Miriam Longo, Paola Caruso, Lorenzo Scappaticcio, Maria Ida Maiorino, Giuseppe Bellastella, Annalisa Capuano, Katherine Esposito, Dario Giugliano
Two years with GIOIA 'Effects of gliflozins and gliptins on markers of cardiovascular damage in type 2 diabetes': A prospective, multicentre, quasi-experimental study on sodium-glucose cotransporter 2 and dipeptidyl peptidase-4 inhibitors in diabetes clinical practice. Diabetes, obesity & metabolism 26 (4) (2024)
Miriam Longo, Paola Caruso, Lorenzo Scappaticcio, Maria Ida Maiorino, Giuseppe Bellastella, Annalisa Capuano, Katherine Esposito, Dario Giugliano
Two years with GIOIA 'Effects of gliflozins and gliptins on markers of cardiovascular damage in type 2 diabetes': A prospective, multicentre, quasi-experimental study on sodium-glucose cotransporter 2 and dipeptidyl peptidase-4 inhibitors in diabetes clinical practice. Diabetes, obesity & metabolism 26 (4) (2024)
Dario Giugliano, Katherine Esposito, Luca De Nicola
Diabetic kidney disease: The fourth pharmacological pillar may be semaglutide. Diabetes, obesity & metabolism (2024)
Miriam Longo, Paola Caruso, Lorenzo Scappaticcio, Maria Ida Maiorino, Giuseppe Bellastella, Annalisa Capuano, Katherine Esposito, Dario Giugliano
Two years with GIOIA 'Effects of gliflozins and gliptins on markers of cardiovascular damage in type 2 diabetes': A prospective, multicentre, quasi-experimental study on sodium-glucose cotransporter 2 and dipeptidyl peptidase-4 inhibitors in diabetes clinical practice. Diabetes, obesity & metabolism (2024)
Dario Giugliano, Miriam Longo, Lorenzo Scappaticcio, Paola Caruso, Maurizio Gicchino, Michela Petrizzo, Giuseppe Bellastella, Maria Ida Maiorino, Katherine Esposito
BEYOND 2 years: durability of metabolic benefits by simplification of complex insulin regimens in type 2 diabetes. Endocrine (2023)
Dario Giugliano, Lorenzo Scappaticcio, Miriam Longo, Paola Caruso, Maria Ida Maiorino, Giuseppe Bellastella, Antonio Ceriello, Paolo Chiodini, Katherine Esposito
GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs. Cardiovascular diabetology 20 (1) (2021)
Dario Giugliano, Miriam Longo, Paola Caruso, Maria Ida Maiorino, Giuseppe Bellastella, Katherine Esposito
Sodium-glucose co-transporter-2 inhibitors for the prevention of cardiorenal outcomes in type 2 diabetes: An updated meta-analysis. Diabetes, obesity & metabolism 23 (7) (2021)
Dario Giugliano, Lorenzo Scappaticcio, Miriam Longo, Giuseppe Bellastella, Katherine Esposito
GLP-1 receptor agonists vs. SGLT-2 inhibitors: the gap seems to be leveling off. Cardiovascular diabetology 20 (1) (2021)
Maria Ida Maiorino, Simona Signoriello, Antonietta Maio, Paolo Chiodini, Giuseppe Bellastella, Lorenzo Scappaticcio, Miriam Longo, Dario Giugliano, Katherine Esposito
Effects of Continuous Glucose Monitoring on Metrics of Glycemic Control in Diabetes: A Systematic Review With Meta-analysis of Randomized Controlled Trials. Diabetes care 43 (5) (2021)
Dario Giugliano, Miriam Longo, Lorenzo Scappaticcio, Giuseppe Bellastella, Maria Ida Maiorino, Katherine Esposito
SGLT-2 inhibitors and cardiorenal outcomes in patients with or without type 2 diabetes: a meta-analysis of 11 CVOTs. Cardiovascular diabetology 20 (1) (2021)
Paola Caruso, Lorenzo Scappaticcio, Maria Ida Maiorino, Katherine Esposito, Dario Giugliano
Up and down waves of glycemic control and lower-extremity amputation in diabetes. Cardiovascular diabetology 20 (1) (2021)
Dario Giugliano, Miriam Longo, Paola Caruso, Rosa Di Fraia, Lorenzo Scappaticcio, Maurizio Gicchino, Michela Petrizzo, Giuseppe Bellastella, Maria Ida Maiorino, Katherine Esposito
Feasibility of Simplification From a Basal-Bolus Insulin Regimen to a Fixed-Ratio Formulation of Basal Insulin Plus a GLP-1RA or to Basal Insulin Plus an SGLT2 Inhibitor: BEYOND, a Randomized, Pragmatic Trial. Diabetes care 44 (6) (2021)
Dario Giugliano, Maria Ida Maiorino, Giuseppe Bellastella, Katherine Esposito
The residual cardiorenal risk in type 2 diabetes. Cardiovascular diabetology 20 (1) (2021)
Maria Ida Maiorino, Miriam Longo, Lorenzo Scappaticcio, Giuseppe Bellastella, Paolo Chiodini, Katherine Esposito, Dario Giugliano
Improvement of glycemic control and reduction of major cardiovascular events in 18 cardiovascular outcome trials: an updated meta-regression. Cardiovascular diabetology 20 (1) (2021)
Dario Giugliano, Miriam Longo, Lorenzo Scappaticcio, Paola Caruso, Katherine Esposito
Sodium-glucose transporter-2 inhibitors for prevention and treatment of cardiorenal complications of type 2 diabetes. Cardiovascular diabetology 20 (1) (2021)
Miriam Longo, Lorenzo Scappaticcio, Giuseppe Bellastella, Vlenia Pernice, Paolo Cirillo, Antonietta Maio, Filomena Castaldo, Dario Giugliano, Katherine Esposito, Maria Ida Maiorino, null null
Alterations in the Levels of Circulating and Endothelial Progenitor Cells Levels in Young Adults with Type 1 Diabetes: A 2-Year Follow-Up from the Observational METRO Study. Diabetes, metabolic syndrome and obesity : targets and therapy 13 (2020)
Dario Giugliano, Giuseppe Bellastella, Miriam Longo, Lorenzo Scappaticcio, Maria Ida Maiorino, Paolo Chiodini, Katherine Esposito
Relationship between improvement of glycaemic control and reduction of major cardiovascular events in 15 cardiovascular outcome trials: A meta-analysis with meta-regression. Diabetes, obesity & metabolism 22 (8) (2020)
Paola Caruso, Miriam Longo, Simona Signoriello, Maurizio Gicchino, Maria Ida Maiorino, Giuseppe Bellastella, Paolo Chiodini, Dario Giugliano, Katherine Esposito
Diabetic Foot Problems During the COVID-19 Pandemic in a Tertiary Care Center: The Emergency Among the Emergencies. Diabetes care 43 (10) (2020)
Dario Giugliano, Juris J Meier, Katherine Esposito
Heart failure and type 2 diabetes: From cardiovascular outcome trials, with hope. Diabetes, obesity & metabolism 21 (5) (2019)
Dario Giugliano, Antonio Ceriello, Luca De Nicola, Pasquale Perrone-Filardi, Francesco Cosentino, Katherine Esposito
Primary versus secondary cardiorenal prevention in type 2 diabetes: Which newer anti-hyperglycaemic drug matters? Diabetes, obesity & metabolism 22 (2) (2019)
Dario Giugliano, Luca De Nicola, Maria Ida Maiorino, Giuseppe Bellastella, Katherine Esposito
Type 2 diabetes and the kidney: Insights from cardiovascular outcome trials. Diabetes, obesity & metabolism 21 (8) (2019)
Dario Giugliano, Maria Ida Maiorino, Giuseppe Bellastella, Miriam Longo, Paolo Chiodini, Katherine Esposito
GLP-1 receptor agonists for prevention of cardiorenal outcomes in type 2 diabetes: An updated meta-analysis including the REWIND and PIONEER 6 trials. Diabetes, obesity & metabolism 21 (11) (2019)
Dario Giugliano, Maria Ida Maiorino, Miriam Longo, Giuseppe Bellastella, Paolo Chiodini, Katherine Esposito
Type 2 diabetes and risk of heart failure: a systematic review and meta-analysis from cardiovascular outcome trials. Endocrine 65 (1) (2019)
Dario Giugliano, Katherine Esposito
Class effect for SGLT-2 inhibitors: a tale of 9 drugs. Cardiovascular diabetology 18 (1) (2019)
Dario Giugliano, Maria Ida Maiorino, Giuseppe Bellastella, Katherine Esposito
Glycemic control in type 2 diabetes: from medication nonadherence to residual vascular risk. Endocrine 61 (1) (2018)
Maria Ida Maiorino, Giuseppe Bellastella, Dario Giugliano, Katherine Esposito
From inflammation to sexual dysfunctions: a journey through diabetes, obesity, and metabolic syndrome. Journal of endocrinological investigation 41 (11) (2018)
Maria Ida Maiorino, Paolo Chiodini, Giuseppe Bellastella, Lorenzo Scappaticcio, Miriam Longo, Katherine Esposito, Dario Giugliano
Free and fixed-ratio combinations of basal insulin and GLP-1 receptor agonists versus basal insulin intensification in type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials. Diabetes, obesity & metabolism 20 (9) (2018)
Dario Giugliano, Maria Ida Maiorino, Giuseppe Bellastella, Katherine Esposito
Comment on Edelman and Polonsky. Type 2 Diabetes in the Real World: The Elusive Nature of Glycemic Control. Diabetes Care 2017;40:1425-1432. Diabetes care 41 (2) (2018)
Dario Giugliano, M I Maiorino, G Bellastella, K Esposito
Clinical inertia, reverse clinical inertia, and medication non-adherence in type 2 diabetes. Journal of endocrinological investigation 42 (5) (2018)
Dario Giugliano, Maria Ida Maiorino, Giuseppe Bellastella, Katherine Esposito
More sugar? No, thank you! The elusive nature of low carbohydrate diets. Endocrine 61 (3) (2018)
Dario Giugliano, Maria Ida Maiorino, Giuseppe Bellastella, Katherine Esposito
Type 2 diabetes and cardiovascular prevention: the dogmas disputed. Endocrine 60 (2) (2017)